Bridge Medicines Announces Additional Funding of $10 Million from Inside Investors
Nov 12, 2020•over 4 years ago
Amount Raised
$10 Million
Description
Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the additional funding of $10 million to advance its current pipeline of products as well as expand with additional in-licensed technologies.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech